Log In
Print
BCIQ
Print
Print this Print this
 

NKTR-214

  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionImmunostimulatory cytokine engineered to selectively activate IL-2 receptors on cytotoxic T cells
Molecular Target
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today